Key Financial Data Of Group

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7718392

Concept 2018-07-01 to
2018-09-30
2018-04-01 to
2018-09-30
As at
2018-09-30
2017-04-01 to
2018-03-31
As at
2018-03-31
2017-07-01 to
2017-09-30
2017-04-01 to
2017-09-30
As at
2017-09-30
Key financial data of group
Business results of group
Net sales
47,521,000,000 JPY
98,430,000,000 JPY
49,860,000,000 JPY
Ordinary profit (loss)
12,536,000,000 JPY
27,854,000,000 JPY
15,517,000,000 JPY
Profit (loss) attributable to owners of parent
8,840,000,000 JPY
19,043,000,000 JPY
10,868,000,000 JPY
Comprehensive income
9,848,000,000 JPY
20,753,000,000 JPY
12,254,000,000 JPY
Net assets
117,180,000,000 JPY
113,874,000,000 JPY
108,406,000,000 JPY
Total assets
152,434,000,000 JPY
152,417,000,000 JPY
148,590,000,000 JPY
Basic earnings (loss) per share
120.80
220.84
470.54
133.74
267.56
Diluted earnings per share
Equity-to-asset ratio
0.769 xbrli:pure
0.747 xbrli:pure
0.730 xbrli:pure
Net cash provided by (used in) operating activities
7,040,000,000 JPY
21,703,000,000 JPY
11,086,000,000 JPY
Net cash provided by (used in) investing activities
-1,217,000,000 JPY
-3,245,000,000 JPY
-822,000,000 JPY
Net cash provided by (used in) financing activities
-6,541,000,000 JPY
-9,530,000,000 JPY
-6,500,000,000 JPY
Cash and cash equivalents
51,976,000,000 JPY
52,694,000,000 JPY
47,530,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.